AffiAB®​ PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF640R conjugate, 0.1mg/mL Antibody

https://www.affiab.com/web/image/product.template/489305/image_1920?unique=d31c23b
(0 review)

CAT# AFG-BTM-16539
Size: 100 μL

380.40 380.40000000000003 USD 380.40

380.40

For Price Contact info@affigen.com

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Overview

PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Conjugate

CF640R.

Concentration

0.1 mg/mL.

Storage Buffer

PBS, 0.1% BSA, 0.05% azide.

Product Applications

.

Storage Temperature

2°C to 8°C.

Stability

Stable at room temperature or 37°C (98°F) for 7 days.